Enhancing vaccine clinical trials participation among elderly: challenges and strategies
Abstract As the fastest growing demographic worldwide, the elderly population is projected to reach nearly 1 billion by 2030 and double the 2022 number by 2050. Despite being the largest consumers of medications, they have been historically underrepresented in clinical trials. However, we are witnes...
Saved in:
Main Authors: | Paul Gillard, Samer Nakhle, Darin Brimhall, Ouzama Henry, Narcisa Mesaros |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Trials |
Online Access: | https://doi.org/10.1186/s13063-025-08754-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01) -
PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
by: Sanaul Mustafa, et al.
Published: (2025-01-01) -
Challenging a paradigm: Staggered versus single-pulse mass dog vaccination strategy for rabies elimination.
by: Brinkley Raynor Bellotti, et al.
Published: (2025-02-01) -
Open challenges for the automatic synthesis of clinical trials
by: Olivia Sanchez-Graillet, et al.
Published: (2025-02-01) -
The case for development of a core outcome set (COS) and supplemental reporting guidelines for influenza vaccine challenge trial research in swine
by: Sheila Keay, et al.
Published: (2025-02-01)